Basilea Pharmaceutica
BSLN.SW
#6276
Rank
S$1.32 B
Marketcap
S$107.26
Share price
0.00%
Change (1 day)
41.22%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2025: S$73.93 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are S$0.29 Billion. In 2025 the company made an earning of S$73.93 Million a decrease over its 2024 earnings that were of S$85.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2025

Annual earnings

Year Earnings Change
2025S$73.93 M-13.15%
2024S$85.13 M436.2%
2023S$15.87 M-5.02%
2022S$16.71 M-276.18%
2021-S$9.49 Million-55.31%
2020-S$21.23 Million-28%
2019-S$29.49 Million-27.06%
2018-S$40.43 Million62.13%
2017-S$24.94 Million-60.94%
2016-S$63.83 Million-19.67%
2015-S$79.46 Million48.25%
2014-S$53.6 Million12.95%
2013-S$47.46 Million-35.16%
2012-S$73.19 Million-5.75%
2011-S$77.65 Million-152.57%
2010S$0.14 B-199.59%
2009-S$0.15 Billion-15.54%
2008-S$0.18 Billion22.84%
2007-S$0.15 Billion60.07%
2006-S$89.31 Million85.69%
2005-S$48.1 Million-43.04%
2004-S$84.45 Million47.04%
2003-S$57.43 Million-37.5%
2002-S$91.88 Million